| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 5.02B | 4.55B | 4.12B | 3.61B | 3.21B |
| Gross Profit | 606.10M | 529.90M | 446.70M | 370.90M | 382.80M |
| EBITDA | 248.50M | 209.30M | 162.90M | 111.00M | 147.00M |
| Net Income | 174.90M | 131.70M | 117.70M | 60.90M | 97.90M |
Balance Sheet | |||||
| Total Assets | 2.45B | 2.13B | 2.03B | 1.79B | 1.71B |
| Cash, Cash Equivalents and Short-Term Investments | 590.50M | 544.20M | 541.30M | 431.70M | 468.60M |
| Total Debt | 181.70M | 118.50M | 144.40M | 134.00M | 163.40M |
| Total Liabilities | 1.70B | 1.48B | 1.46B | 1.30B | 1.23B |
| Stockholders Equity | 748.80M | 647.20M | 568.10M | 496.20M | 474.20M |
Cash Flow | |||||
| Free Cash Flow | 189.90M | 110.60M | 181.40M | 42.90M | 102.50M |
| Operating Cash Flow | 205.90M | 128.80M | 196.00M | 54.70M | 110.50M |
| Investing Cash Flow | -44.80M | 4.70M | -11.00M | 8.30M | -4.50M |
| Financing Cash Flow | -122.30M | -101.80M | -78.90M | -66.80M | -80.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | £1.47B | 8.23 | 23.46% | 3.08% | -1.17% | 12.31% | |
73 Outperform | £2.10B | 12.50 | 24.53% | 2.49% | 6.93% | 21.50% | |
72 Outperform | £513.80M | 7.10 | 30.23% | 3.65% | 5.78% | -6.80% | |
71 Outperform | £3.98B | 13.49 | 23.73% | 1.80% | 9.97% | -15.46% | |
71 Outperform | £879.47M | 9.81 | 11.69% | 3.19% | 4.40% | 31.59% | |
70 Outperform | £1.81B | 20.83 | 17.34% | 2.34% | 3.88% | 5.10% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |